No connection

Search Results

BME

BEARISH
$42.19 Live
BlackRock Health Sciences Trust · NYSE
$34.18 52W Range $42.51

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$545.27M
P/E
N/A
ROE
-4.6%
Profit margin
N/A
Debt/Equity
0.0
Dividend yield
7.43%

AI Analysis

AI-powered fundamental assessment

Confidence
65%
The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full bankruptcy risk assessment. Despite a high dividend yield of 7.43%, the unsustainable 162.83% payout ratio raises concerns about dividend continuity. Profitability metrics show mixed signals with a 100% gross margin but zero profit margin and negative ROE of -4.63%, suggesting underlying operational inefficiencies. The technical trend score of 10/100 indicates strong bearish momentum, further weakening the investment case.

Key Strengths

High dividend yield of 7.43% offers attractive income potential
Zero debt with a Debt/Equity ratio of 0.00 enhances financial flexibility
100% gross margin reflects strong pricing power or low cost of goods sold
Operating margin of 24.48% is robust relative to peers
Recent price performance shows strong short-term momentum with +20.6% over 6 months

Key Risks

Piotroski F-Score of 5 indicates only moderate financial strength, limiting downside protection
Extremely low current and quick ratios (0.09) signal severe liquidity risk
Unsustainable dividend payout ratio of 162.83% threatens future distributions
Negative ROE (-4.63%) reflects poor return on shareholder equity
Technical trend score of 10/100 suggests strong bearish price momentum near term

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
46
Moderate
Value
35
Future
40
Past
55
Health
48
Dividend
50
AI Verdict
Caution advised due to liquidity and profitability concerns
Key drivers: Low liquidity ratios, Unsustainable dividend payout, Negative ROE, Strong operating margin, Zero leverage
Confidence
68%
Value
35/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book of 1.07 suggests near-book valuation
Watchpoints
  • Price/Sales of 73.00 is extremely high, indicating overvaluation
  • No Graham Number available for defensive valuation benchmark
Future
40/100

Ref Growth rates

Positives
  • Revenue decline is minimal at -2.40% YoY
Watchpoints
  • Negative earnings growth trend
  • No forward P/E or growth estimates available
Past
55/100

Ref Historical trends

Positives
  • 5Y return of +19.4% outperforms many peers
  • 1Y return of +13.7% shows recent resilience
Watchpoints
  • Lack of historical averages (50D/200D) limits trend analysis
Health
48/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 5 indicates stable financial condition
  • Debt/Equity of 0.00 eliminates solvency risk from leverage
Watchpoints
  • Current Ratio of 0.09 indicates near-term liquidity crisis
  • No Altman Z-Score available for distress prediction
Dividend
50/100

Ref Yield, Payout

Positives
  • Dividend yield of 7.43% is attractive in current rate environment
Watchpoints
  • Payout ratio of 162.83% is unsustainable long-term
  • Dividend Strength score of 40/100 indicates weak reliability

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$42.19

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BME and closest competitors.

Updated 2026-01-23
BME
BlackRock Health Sciences Trust
Primary
5Y
+19.4%
3Y
+22.4%
1Y
+13.7%
6M
+20.6%
1M
+2.5%
1W
+1.8%
NRI
Northrim BanCorp, Inc.
Peer
5Y
+178.5%
3Y
+143.9%
1Y
+43.0%
6M
+15.8%
1M
+7.8%
1W
+2.8%
CAR
Carter Bankshares, Inc.
Peer
5Y
+81.6%
3Y
+83.5%
1Y
+59.6%
6M
+28.7%
1M
+20.2%
1W
+0.3%
ACI
American Coastal Insurance Corporation
Peer
5Y
+65.7%
3Y
+399.5%
1Y
+1.6%
6M
+9.0%
1M
+2.3%
1W
-2.8%
DPG
Duff & Phelps Utility and Infrastructure Fund Inc.
Peer
5Y
+58.6%
3Y
+45.6%
1Y
+29.1%
6M
+14.2%
1M
+2.2%
1W
+0.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.07
P/S Ratio
73.0
EV/Revenue
73.19
EV/EBITDA
N/A
Market Cap
$545.27M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin 24.48%
Gross Margin 100.0%
ROE -4.63%
ROA 0.11%

Growth

Revenue and earnings growth rates

Revenue Growth -2.4%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
0.09
Weak
Quick Ratio
0.09
Poor
Cash/Share
$0.0

Financial Services Sector Comparison

Comparing BME against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
Return on Equity (ROE)
-4.63%
This Stock
vs
-0.73%
Sector Avg
+532.4% (Excellent)
Debt to Equity
0.0
This Stock
vs
1.36
Sector Avg
-99.8% (Less Debt)
Revenue Growth
-2.4%
This Stock
vs
35.27%
Sector Avg
-106.8% (Slower)
Current Ratio
0.09
This Stock
vs
3.18
Sector Avg
-97.3% (Weaker)

Similar Companies

Peer comparison within the same industry

Past News Coverage

Recent headlines mentioning BME from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile